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a b s t r a c t
The life threatening disease of sepsis is associated with high
mortality. Septic patient survivability with currently available
treatments has failed to improve. The purpose of this study was to
evaluate whether lipopolysaccharide (LPS) induced sepsis mortal-
ity and associated hepatic dysfunction can be prevented by cerium
oxide nanoparticles (CeO2NPs) treatment in male Sprague Dawley
rats. Here we provide the information about the methods
processing of raw data related to our study published in
Biomaterials (Selvaraj et al., Biomaterials, 2015, In press) and Data
in Brief (Selvaraj et al., Data in Brief, 2015, In Press). The data
present here provides confirmation of cerium oxide nanoparticle
treatments ability to prevent the LPS induced sepsis associated
changes in physiological, blood cell count, inflammatory protein
and growth factors in vivo. In vitro assays investigation the treated
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of macrophages cells with different concentrations of cerium oxide
nanoparticle demonstrate that concentration of cerium oxide
nanoparticles below 1 mg/ml did not significantly influence cell
survival as determined by the MTT assay.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Specifications table (please fill in right-hand column of the table below)
Value of the data
 The data can be referenced by other scientists investigating the effects of LPS on animal behavior
and serum cytokine/chemokine levels.
 The data can provide comprehensive analysis of the effect of cerium oxide nanoparticles on LPS-
induced sepsis.
 These data provides a more thorough understanding of the hepatic involvement in LPS-induced
sepsis.
1. Data, experimental design, materials and methods
1.1. Experimental design and methods
This data articles contains data related to the research articles entitled “Inhibition of MAP kinase/
NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium
oxide nanoparticles” in Biomaterials [1]. In the present study we have confirmed how the
administration of a single dose (0.5 mg/kg) of CeO2NPs intravenously into septic rats prevent the
LPS induced sepsis associated physiological, blood cell count and inflammatory protein and growth
factors changes. In addition to that we treated the macrophages cells with different concentrations of
cerium oxide nanoparticle to determine the range of cytotoxic and non-cytotoxic concentrations.
Finally we have hypothesized the potential mechanistic model of LPS induced sepsis. Concentration of
cerium oxide nanoparticles below 1 mg/ml did not appears to significantly influence cell survival as
determined by the MTT assay. Finally we have showed the mechanistic insight of systemic
inflammatory response syndrome (SIRS) of sepsis and effect of CeO2 nanoparticles treatment.
Subject area Biology
More specific subject
area
Nanomedicine
Type of data Table and figure
How data was
acquired
Observational data, MTT assay, complete blood count, cytokine array
Data format Raw and analyzed
Experimental factors Rodent based intervention study examining the effects of cerium oxide nanoparticle treatment on
LPS induced sepsis.
Experimental
features
Balanced design that encompasses both in vivo and in vitro observations
Data source location Huntington, WV USA
Data accessibility The data presented in this article and is related to [1,2]
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1.1.1. Animal preparation and experimental design
Male Sprague-Dawley rats weighing 300–350 g were obtained from Charles River laboratories and
housed two per cage using a 12:12- h dark-light cycle at a temperature of 2272 1C. Animals were
provided food and water ad libitum and allowed to acclimate for at least two week prior to any
experimentation. Animals were randomly assigned to the following groups: control group (n¼6)
received 1.5 ml of endotoxin free water by i.p., CeO2 nanoparticle treated group (n¼6) received 1.5 ml
of endotoxin free water by i.p., and CeO2 nanoparticles (0.5 mg/kg) in 200 ml of sterile distilled water
via the tail vein. All procedures were performed as outlined in the guide for the care and use of
laboratory animals as approved by the council of the American physiological society and the
institutional animal use review board of Marshall University.
1.1.2. SDS-PAGE and immunoblotting
Approximately 100 mg of frozen tissue was taken and pulverized in liquid nitrogen and added to
900 ml of T-PER (Pierce, Rockford, IL, USA) containing 1% protease and phosphatase inhibitors (P8340 and
P5726, Sigma- Aldrich, St. Louis, MO, USA). Samples were homogenized and centrifuged at 13,000 rpm for
10 min at 4 1C to collect the supernatant. Amount of protein in the samples was estimated through
660 nm assay (Pierce, Rockford, IL, USA) and normalized with T-PER and 4 Laemlli buffer to a final equal
concentration across all samples. Equal amount of protein was loaded in 10% PAGEr Gold Precast gel
(Lonza, Rockland, ME) and transferred to nitrocellulose membranes using standard protocol. Membranes
were block with 5% milk in TBST for 1 h at room temperature, washed thrice with TBST and probed for
detection of MyD-88, total and P-p-38 MAPK, total and P- p-ERK 1/2 MAPK (44/42), iNOS, COX-2, HMGB1,
Total and cleaved caspase-3, Bax and Bcl-2, GAPDH (Cell Signaling Technology, Danvers, MA). Membranes
were incubated with primary antibody overnight at 4 1C, washed with TBST (35 min), and incubated
with secondary anti-rabbit (Cell Signaling Technology, Danvers, MA) for 1 h at room temperature.
Immunoreactive signal was visualized using Supersignal West Pico Chemiluminiscent substrate (Pierce,
Rockford, IL, USA) and quantified using Fluorchem 9900 software (Protein Simple, Santa Clara, CA). Protein
expression was normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
1.1.3. TUNEL assay
TUNEL staining was performed on tissue sections (5 mm) of frozen samples, which were dewaxed and
rehydrated according to the manufactures recommendation (Roche Applied Science, Indianapolis, IN).
Additional experiments were performed in parallel using DNaseI or the omission of labeling reagent was
used as positive and negative control. Images were captured using an EVOSfl fluorescence (Fisher
Scientific, Pittsburgh, PA, USA) microscope at 200 magnification. TUNEL positive apoptotic nuclei were
counted and expressed as the number of TUNEL-positive nuclei per 500 nuclei (TUNELþ/500 nuclei).
1.1.4. Macrophage culture and uptake of CeO2 NPs and protective effective of CeO2 NPs against LPS
RAW264.7 cells from (ATCC) were grown in 25 cm2 cell culture flasks at 30 1C with 5% CO2 in DMEM
high glucose medium containing 1% Pen/Strep (10,000 U Penicillin and 10mg Streptomycin/ml) and
supplemented with 5% of fetal bovine serum. The cytotoxic and non-cytotoxic concentration of CeO2
nanoparticles was determined by MTT assay. The protective effect of CeO2 nanoparticles again LPS induced
cytotoxicity was measured by MTT assay as follows. RAW 264.7 (1.2105/ml) were grown in 24 well tissue
culture plates until 70–80% confluence and the media was replaced with the fresh medium containing
different doses of CeO2 NPs (0, 1, 5, 10, 25, 50, 100 and 1000 ng/ml) for 24 h in the absence and presence of
LPS and performed MTT assay. To examine if the CeO2 nanoparticles exhibit the ability to sequester or
neutralize LPS functionality of LPS, different doses of CeO2 NPs (0, 1, 5, 10, 25, 50, 100, or 1000 ng/ml) were
incubated for 2 h at room temperature in growthmedium in the presence or absence of LPS (2 mg/ml). After
centrifugation (5000 g for 10min) to pellet any suspended nanoparticles, the now clarifiedmedia (500 ml)
was added to cultured RAW 264.7 cells for 24 h and the MTT assay performed as detailed previously.
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1.1.5. Determination of reactive oxygen species (ROS), mitochondrial membrane potential (Δψm), nitric
oxide (NO) and cytokine levels
Reactive oxygen species (ROS) levels were determined following the addition of 2, 7-
dichlorodihydrofluorescein diacetate (DCFH-DA), using the OxiSelectTM kit from Cell Bio Labs (San
Diego, CA) as outlined by the manufacturer. The assay employs the cell-permeable fluorogenic probe
(DCFH-DC). The DCFH-DC is diffused into cells and is deacctylated by cellular esterases to non-
fluorescent DCFH, which is rapidly oxidized to highly fluorescent 20,70-dichlorodihydrofluorescein(DCF)
by ROS. Briefly, RAW cells were grown in 24-well plates, after the treatment period, cells were washed
with cold PBS and incubated in serum-free mediumwith 100 ml of 1 DCFH-DA reagent and incubated
at 37 1C for 1 h. Following this incubation period, cells were washed twice with DPBS and terminated
the assay by adding 100 ml of the 2 cell lysis buffer and, the fluorescence of each cell suspension was
measured with a fluorometric plate reader (Spectramax, Gemini EM) at 480 nm/530 nm. Observation of
dye uptake by cells was determined following imaging using an EVOSfl fluorescence (Fisher Scientific,
Pittsburgh, PA, USA) microscope equipped with a GFP filter.
The extent of mitochondrial membrane damage was determined by measuring mitochondrial
membrane potential (Δψm), using the JC 1 dye (Cell Technology, Mountain View, CA). Experimentally
treated cells were washed with cold PBS, removed with trypsin and centrifuged at 400 g for 10 min. The
resulting pellets were then re-suspended in PBS and the cell density adjusted to 1105 cells/ml. Aliquots
(200 ml each) were then centrifuged at 400 g for 5 min, and the resulting cell pellets were assayed for
mitochondrial membrane damage. In the absence of mitochondrial damage, the JC-1 dye accumulates in
the organelle and fluoresces red. Conversely, an inability of the mitochondria to concentrate JC-1 dye
results in the accumulation of the dye in the cytoplasm and a green fluorescence. Overall fluorescence was
measured with a fluorometric plate reader (Spectramax, Gemini EM) at 535 nm and 600 nm for green and
red fluorescence, respectively. Observation of dye uptake by mitochondria was determined following
imaging under fluorescence (EVOSfl Model, Fisher Scientific, Pittsburgh, PA, USA).
RAW 264.7 cells were treated with different concentration of CeO2 nanoparticles in the presence
and absence of LPS (2 mg/ml) for 24 h. Nitrite production in the culture supernatants was assayed
using the Griess reaction kit from Cayman Chemical Company (Ann Arbor, Michigan, USA). One
hundred microliters was removed from the medium and incubated with an equal volume of Griess
reagent for 30 min at room temperature and the absorbance was measured at 540 nm in an ELISA
reader (BioTek, Instrument, Inc., Winooski, Vermont, USA) as outlined by the manufacturer. Nitrite
concentration was calculated with reference to a standard curve obtained using NaNO2.
Cells were cultured for 24 h in the presence of CeO2 nanoparticles with and without LPS. Cell
culture media was recovered by centrifugation at 400 g for 10 min. The concentration of TNF-α, IL-6,
and IL-1β in the media was measured by ELISA reagent kits (BD Bioscience, Franklin Lakes, NJ, USA) as
detailed by the manufacture. HMGB1 concentration in the media was estimated by ELISA reagent kits
(Chondrex Inc, Red mound, WA, USA)
1.1.6. Immunoblotting, electromobility shift assay, and luciferase reporter assay
Cells were washed with cold PBS, collected by scraping and centrifuged at 400 g for 10 min. Total cell
lysates, cytoplasmic, and nuclear fractions were prepared by cell lyticTM M cell lysis reagent (Sigma) and
NE-PER cell lysis buffer (Thermo Scientific, Rockford, IL, USA) as outlined by the manufacturer. Protein
content was estimated in triplicate using the Bradford reagent with bovine serum albumin as a standard.
Western blot was performed as mentioned elsewhere. Fifty mg of total protein per well was then
subjected to electrophoresis and transfer to nitrocellulose Hybond-C membranes (AmershamTM
HybondTM) using standard conditions. Membranes were incubated overnight at 4 1C with the
appropriate primary antibody iNOS, COX-2, IkB-α, and NF-kβ ( Cell Signaling, Dnavers, MA), washed
extensively and then incubated for 1 h at room temperature with a horse radish peroxidase labeled anti-
rabbit before detection by ECL (Western Blotting Detection Reagent, GE Health Care Amersham,
Piscataway, NJ). Immunoreactive signals were quantified by densitometry using Alpha Innotech software
(Santa Clara, California). Beta actin immunoreactivity was used for normalization between samples.
The electromobility shift (EMSA) assay was performed using a commercially available kit (Pierce,
Rockford, IL, USA) as detailed by the manufacturer Briefly, 5 mg of the nuclear protein extract was used
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Table 1
Effect of CeO2 nanoparticles on LPS induced septic symptoms (physical behavior and morphological changes).
Physical behavior External symptoms/sign Score Control & CeO2 LPS
0 h 6 h 12 h 24 h 48 h 72 h 96 h 120 h 144 h 168 h 0 h 6 h 12 h 24 h 48 h 72 h
Appearance Normal, Smooth Fur 0 0 0 0 0 0 0 0 0 0 0 0 0
Roughened Fur 1 1 1 1 1
Wet Fur 2
Mucous eyes 3
Breathing Normal 0 0 0 0 0 0 0 0 0 0 0 0 0
Fast 1 1 1 1 1
Slow 2
Weak and intermittent 3
Weight changes j 5% 0 0 0
j 15% 1 1
j 20 % 2 2 2 2 2 2 2 2 2 2 2 2 2 2
Greater than j 20% 3
Behavior Normal, agile, prying 0 0 0 0 0 0 0 0 0 0 0 0 0
Slow movement, sitting position 1 1 1 1 1
Dull, Sloughed, tottering movements 2
Lateral position 3
Provoked reaction Escape reaction when cage is opened 0 0 0 0 0 0 0 0 0 0 0 0
Fight when approached by hand 1
Flight when touched 2
No flight reaction at all 3 3 3 3 3 3
Physical behavior External symptoms/sign Score LPS LPS+CeO2
96 h 126 h 144 h 168 h 0 h 6 h 12 h 24 h 48 h 72 h 96 h 120 h 144 h 168 h
Appearance Normal, Smooth Fur 0 0 0 0 0 0 1 0 0 0 0 0 0
Roughened Fur 1 1 1
Wet Fur 2
Mucous eyes 3
Breathing Normal 0 0 0 0 0 0 0 0 0 0 0 0 0
Fast 1 1 1
Slow 2
Weak and intermittent 3
Weight changes j 5% 0
j 15% 1
j 20 % 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2
Greater than j 20% 3
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Table 1 (continued )
Physical behavior External symptoms/sign Score LPS LPS+CeO2
96 h 126 h 144 h 168 h 0 h 6 h 12 h 24 h 48 h 72 h 96 h 120 h 144 h 168 h
Behavior Normal, agile, prying 0 0 0 0 0 0 0 0 0 0 0 0
Slow movement, sitting position 1 1 1 1
Dull, Sloughed, tottering movements 2
Lateral position 3
Provoked reaction Escape reaction when cage is opened 0 0 0 0 0 0 0 0 0 0 0
Fight when approached by hand 1 1 1 2 2
Flight when touched 2
No flight reaction at all 3
Result: Control (n=6), CeO2 (n=6), LPS (n=12) and LPS+ CeO2 (n=12).
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Table 2
Effect of CeO2 nanoparticles on LPS induced changes in blood cells.
Whole blood cells counts
6 h 24 h
Control CeO2 Sepsis SepsisþCeO2 Control CeO2 Sepsis SepsisþCeO2
WBC (109/l) 3.0370.36 2.8170.38 1.3970.27* 1.2770.44 3.470.74 2.9970.46 2.83570.39 2.8770.45
Lymphocytes (109/l) 2.0070.20 0.8270.20* 0.3770.05* 0.8270.11*# 2.4070.55 1.9670.12 0.5470.54* 0.4370.44
Monocytes (109/l) 0.0870.04 0.1170.06 0.0770.03 0.0370.00 0.1870.05 0.15570.04 0.1770.05 0.2270.05
Granulocytes (109/l) 1.0370.18 1.8770.32* 0.94670.12 0.61670.34 0.81570.16 0.87570.34 2.1370.29* 2.2170.38
Lymphocytes (%) 65.8074.11 50.8576.69 27.8872.07* 62.9678.53*# 70.0073.79 68.7574.75 19.4171.79* 15.8071.15
Monocytes (%) 2.5571.20 1.9571.71 5.16671.61 2.9870.75 5.1870.74 6.5872.01 6.4171.85 6.7171.72
Granulocytes (%) 31.5673.55 60.7076.13‡ 66.971.19* 29.979.24*# 24.8174.16 24.6476.30 74.1671.81* 76.1872.04
n Po0.05 compared to control group.
n# Po0.05 compared to sepsis group. (n¼6/group).
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Table 3
Effect of CeO2 nanoparticles on LPS induced inflammatory proteins.
Analyte Serum
6 h 24 h
Control CeO2 Sepsis SepsisþCeO2 Control CeO2 Sepsis SepsisþCeO2
Stem cell factor (pg/ml) 545725 616738 15407150* 16367131 655729 666711 1193737* 878758*
Myoglobin (ng/ml) 1540720 738743* 20807141* 1170745* 702745 1710710* 2370780* 1816796*
CD-40 ligand (pg/ml) 42870 42870 964789* 749780 43173 42870 1386796* 1094795*
Fibrinogen (mg/ml) 51070 51070 656747* 540724 51070 51070 1223761* 901719*
Growth hormone (ng/ml) 5566672603 51000722143 6466671333 5600072516* 5600071154 3733371452* 196667666* 563337881*
Heptaglobin (mg/ml) 635721 20372* 22272* 25974* 801721 607715* 1093748* 1326732
Leptin (ng/ml) 360726 446732 1366733* 1300757 41078 406731 1400757* 1433733
IP 10 (pg/ml) 9170 9170 1686718* 1883769 9170 9170 337711* 363710
n Po0.05 compared to control group.
n Po0.05 compared to sepsis group. (n¼6/group).
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LPS
↑ MyD-88
iKB-αNF-kB-p65
↑  NF-kB transcriptional activity
MAP kinase
Phosphorylation
ERK42/44, p-38 , JNK 
↑  ROS
↑ iNOS 
↑ COX-2
↑ Inflammatory cytokines 
    and chemokine's
Nucleus
Kupffer cell
Tissue and other organ damage
Kupffer cell released cytokines and 
chemokine induce liver apoptosis 
and necrosis. CeO2 nanoparticles     
       attenuate release of 
inflammatory mediators.        
Liver
Fig. 2. shows the mechanistic insight of systemic inflammatory response syndrome (SIRS) of sepsis and effect of CeO2
nanoparticles treatment.
Fig. 1. Determination of cytotoxic and non-cytotoxic concentration of CeO2 NPs. *Po0.05 compared to control group.
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in a binding reaction with 1 binding buffer, 2.5% glycerol, 5 mMMgCl2, 50 ng/ml of poly (dI:dC), and
0.05% Nonidet P-40. A double stranded 50-biotin-NF-kB oligonucleotide probe (consensus sequence 50-
AGTTGAGGGGACTTTCCCAGGC-30) was added to the reaction at a final concentration of 10 pM/20 ml
reaction mix. After 30 min, 5 ml of 5 loading buffer was added to the reaction mix, and the samples
were resolved on 6% polyacrylamide gels at 120 V for 55 min using 0.5% TBE before transfer to nylon
membrane at 10 V for 70 min using 0.5% TBE. The protein-DNA probe complexes were cross-linked
with a UV cross linker. NF-kB specific bands were detected by streptavidin-horseradish peroxidase
conjugate using a chemiluminescence nucleic acid detection kit (Thermo scientific, Rockford, IL, USA).
NF-kB reporter construct were purchase from Promega (Madison, WI, USA). For the report assay, cells
were seeded into 24 well plates at a density of 5105 cells per well and transiently transfected with 400 ng
of luciferase reporter construct and 100 ng of internal control plasmid of the pCMV-β-galactosidase reporter
plasmid from Clontech (Mountain view, CA, USA) using lipofectamin TM200 reagent according to the
manufacture’s procedure (In vitrogen, Carlsbad, CA, USA). Twenty four hours after transfection, the cells
were treated with fresh medium containing LPS and LPS þCeO2 nanoparticles for further 24 h. After 24 h,
the luciferase activities were measured in cell lysates using luciferase and x-gal reagents following
manufacture’s instruction (Promega, Madison, WI, USA and Clone tech, Mountain view, CA, USA).
2. Results for the present study
2.1. Physiological behavior and morphological changes
In Table 1 physiological behavior and morphological changes among different experimental groups
is represented. In control animals, there were no changes in appearance, breathing rate, weight
change, and animal behavior and, provoked reaction. Whereas LPS induced septic animals showed
changes in animal morphology, roughened fur, fast breathing rate, slow moment and no flight
reaction at all. In contrast, the behavior and morphological changes of animals from LPSþ CeO2
nanoparticles group was similar to that from the control animals.
2.2. Complete blood cell counts
Table 2 exhibits the result of blood cells count among different experimental groups. Compared to
control animals, the septic animal’s white blood cells count at 6 h and total and percent (%) lymphocytic
count both at 6 and 24 h time points dropped significantly compared to control, whereas percent (%)
granulocyte count at both time points increased significantly. Nanoparticle treatment increased the total
and percent (%) lymphocyte count and decreased the percent (%) granulocyte count significantly.
2.3. Inflammatory protein and growth factors
Table 3 demonstrates the results of inflammatory protein and growth factors among the different
experimental groups. Compared to the data obtained from control animals, septic animals appears in
increased the levels of inflammatory proteins and growth hormones such stem cell factor, myoglobin,
CD-40 ligand, fibrinogen, growth hormone, hepataglobin, leptin and IP-10 both at 6 and 24 h time
points. Nanoparticles treatment decreased LPS-induced myoglobin at 6 h and 24 h and, the stem cell
factor, CD-40, fibrinogen at both time points.
2.4. Cytotoxicity
Fig. 1 reveals the cytotoxic and non-cytotoxic concentration determination in RAW cells.
Concentration of cerium oxide nanoparticles below 1 mg/ml did not appears to significantly influence
cell survival as determined by the MTT assay.
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2.5. Potential mechanistic model
Fig. 2 shows the mechanistic insight of systemic inflammatory response syndrome (SIRS) of sepsis
and effect of CeO2 nanoparticles treatment. The liver plays a central role in lipopolysaccharide (LPS)
induced sepsis. LPS from the circulation may mat illicit a response from the liver causing a release of
cytokines and reactive oxygen mediators. Kupffer cells (macrophages) represent the main cellular
mediators of the effects of LPS in the liver [3]. LPS interacts with Toll like receptor 4 (TLR-4) which is
present on cell membrane of macrophage. As the result of interaction, myeloid differentiation protein 88
(MyD88) initiates early activation of NF-kB. Upon activation TLR4 with LPS, MyD 88 activates Ikβ kinases,
leading to phosphorylation and degradation of IkB and release and translocation of NF-kB to the nucleus
as well as induced expression of proinflammatory gene and expression of pro-inflammatory cytokines
and chemokines, which causes for liver and other organ damage [4]. At the same time, LPS leads to
secrete elevated reactive oxygen species (ROS) which trigger mitogen-activated protein kinase (MAPK)
signaling pathway. Activated MAPK kinase plays a crucial role in the release of specific cytokines and
chemokines which causes for liver and other organ damage [5].
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